Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Yield10 Bioscience Inc YTEN

Healthcare Biotechnology
Yield10 Bioscience, Inc. is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa (Camelina) as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and... see more

Recent & Breaking News (OTCQB:YTEN)

Mid-Morning Market Update: Markets Edge Lower; Darden Restaurants Tops Q2 Expectations

Benzinga.com  December 19, 2017

Yield10 Bioscience Announces Pricing of $12.6 Million Public Offering

GlobeNewswire December 19, 2017

Mid-Afternoon Market Update: NASDAQ Up 0.5%; bluebird bio Shares Spike Higher

Benzinga.com  December 11, 2017

Yield10 Bioscience Grants Research License to Monsanto to Evaluate Two Novel Yield Traits in Soybean

GlobeNewswire December 11, 2017

Yield10 Bioscience CSO Dr. Kristi Snell to Present at CanolaWeek 2017

GlobeNewswire December 7, 2017

Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders

GlobeNewswire November 29, 2017

Yield10 Bioscience Announces Third Quarter 2017 Financial Results

GlobeNewswire November 9, 2017

Yield10 Bioscience to Host Webcast of its Third Quarter 2017 Conference Call

GlobeNewswire November 6, 2017

Yield10 Bioscience to Participate in U.S. Department of Energy Grant for Boosting Oilseed Yield in Camelina

GlobeNewswire September 15, 2017

Yield10 Bioscience Obtains Confirmation of Nonregulated Status from USDA-APHIS for its Genome-edited Camelina Line

GlobeNewswire September 5, 2017

Yield10 Bioscience to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

GlobeNewswire September 5, 2017

Yield10 Bioscience Announces Collaboration with National Research Council of Canada to Improve Yield and Drought Tolerance in Wheat

GlobeNewswire August 8, 2017

Yield10 Bioscience to Host Webcast of its Second Quarter 2017 Conference Call

GlobeNewswire July 27, 2017

10 Biggest Mid-Day Losers For Monday

Benzinga.com  July 3, 2017

Mid-Morning Market Update: Markets Open Higher; Red Ventures To Acquire Bankrate for $14/Share

Benzinga.com  July 3, 2017

Yield10 Bioscience Announces Pricing of $2.3 Million Registered Direct Offering

GlobeNewswire July 3, 2017

Yield10 Bioscience to Report Results Showing that Trait C4001 Produces Significant Increases in Plant Yield

GlobeNewswire June 27, 2017

Yield10 Bioscience CEO Dr. Oliver Peoples to Present at BIO 2017

GlobeNewswire June 20, 2017

Yield10 Bioscience Submits “Am I Regulated?” Letter to USDA-APHIS BRS for Genome-Edited Camelina

GlobeNewswire June 15, 2017

Yield10 Bioscience to Present at the Marcum Microcap Investor Conference

GlobeNewswire June 14, 2017